BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Jelvehgari M. Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: Development, characterization, ex vivo permeation and cellular studies. Colloids Surf B Biointerfaces 2017;159:629-38. [PMID: 28865359 DOI: 10.1016/j.colsurfb.2017.08.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 A P, Agrawal M, Dethe MR, Ahmed H, Yadav A, Gupta U, Alexander A. Nose-to-brain drug delivery for the treatment of Alzheimer's Disease: Current advancements and challenges. Expert Opin Drug Deliv 2022. [PMID: 35040728 DOI: 10.1080/17425247.2022.2029845] [Reference Citation Analysis]
2 Giuliano E, Paolino D, Fresta M, Cosco D. Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview. Pharmaceutics 2018;10:E159. [PMID: 30213143 DOI: 10.3390/pharmaceutics10030159] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 18.8] [Reference Citation Analysis]
3 Chen Y, Cheng G, Hu R, Chen S, Lu W, Gao S, Xia H, Wang B, Sun C, Nie X, Shen Q, Fang W. A Nasal Temperature and pH Dual-Responsive In Situ Gel Delivery System Based on Microemulsion of Huperzine A: Formulation, Evaluation, and In Vivo Pharmacokinetic Study. AAPS PharmSciTech 2019;20. [DOI: 10.1208/s12249-019-1513-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
4 Mahmoudian M, Salatin S, Khosroushahi AY. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery. Cancer Chemother Pharmacol 2018;82:371-82. [DOI: 10.1007/s00280-018-3626-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
5 Laffleur F, Bauer B. Progress in nasal drug delivery systems. Int J Pharm 2021;607:120994. [PMID: 34390810 DOI: 10.1016/j.ijpharm.2021.120994] [Reference Citation Analysis]
6 Katona G, Sipos B, Budai-Szűcs M, Balogh GT, Veszelka S, Gróf I, Deli MA, Volk B, Szabó-Révész P, Csóka I. Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application. Pharmaceutics 2021;13:646. [PMID: 34062873 DOI: 10.3390/pharmaceutics13050646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Gupta U, Kesharwani P, Ravichandiran V, Kumar P, Naidu VGM, Murty US, Ajazuddin, Alexander A. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. J Control Release 2020;327:235-65. [PMID: 32739524 DOI: 10.1016/j.jconrel.2020.07.044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
8 Salatin S, Lotfipour F, Jelvehgari M. Preparation and characterization of a novel thermosensitive and bioadhesive cephalexin nanohydrogel: a promising platform for topical antibacterial delivery. Expert Opin Drug Deliv 2020;17:881-93. [PMID: 32441175 DOI: 10.1080/17425247.2020.1764530] [Reference Citation Analysis]
9 Grillo R, Dias FV, Querobino SM, Alberto-silva C, Fraceto LF, de Paula E, de Araujo DR. Influence of hybrid polymeric nanoparticle/thermosensitive hydrogels systems on formulation tracking and in vitro artificial membrane permeation: A promising system for skin drug-delivery. Colloids and Surfaces B: Biointerfaces 2019;174:56-62. [DOI: 10.1016/j.colsurfb.2018.10.063] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
10 Torabi SJ, Mohebali A, Abdouss M, Shakiba M, Abdouss H, Ramakrishna S, Teo YS, Jafari I, Rezvani Ghomi E. Synthesis and characterization of a novel molecularly imprinted polymer for the controlled release of rivastigmine tartrate. Mater Sci Eng C Mater Biol Appl 2021;128:112273. [PMID: 34474832 DOI: 10.1016/j.msec.2021.112273] [Reference Citation Analysis]
11 Bhanderi M, Shah J, Gorain B, Nair AB, Jacob S, Asdaq SMB, Fattepur S, Alamri AS, Alsanie WF, Alhomrani M, Nagaraja S, Anwer MK. Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies. Materials (Basel) 2021;14:6291. [PMID: 34771817 DOI: 10.3390/ma14216291] [Reference Citation Analysis]
12 Gorain B, Rajeswary DC, Pandey M, Kesharwani P, Kumbhar SA, Choudhury H. Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition. CPD 2020;26:2233-46. [DOI: 10.2174/1381612826666200313125613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
13 Ahmed S, Gull A, Aqil M, Danish Ansari M, Sultana Y. Poloxamer-407 thickened lipid colloidal system of agomelatine for brain targeting: Characterization, brain pharmacokinetic study and behavioral study on Wistar rats. Colloids Surf B Biointerfaces 2019;181:426-36. [PMID: 31176115 DOI: 10.1016/j.colsurfb.2019.05.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
14 Guimarães TMT, Moniz T, Nunes C, Zaharieva MM, Kaleva M, Yoncheva K, Najdenski H, Costa Lima SA, Reis S. Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model. Pharmaceutics 2022;14:752. [DOI: 10.3390/pharmaceutics14040752] [Reference Citation Analysis]
15 Bellotti E, Schilling AL, Little SR, Decuzzi P. Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: A review. J Control Release 2021;329:16-35. [PMID: 33259851 DOI: 10.1016/j.jconrel.2020.11.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
16 Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Alami-Milani M, Jelvehgari M. Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine. Adv Pharm Bull 2020;10:20-9. [PMID: 32002358 DOI: 10.15171/apb.2020.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
17 Gao Y, Almalki WH, Afzal O, Panda SK, Kazmi I, Alrobaian M, Katouah HA, Altamimi ASA, Al-Abbasi FA, Alshehri S, Soni K, Ibrahim IAA, Rahman M, Beg S. Systematic development of lectin conjugated microspheres for nose-to-brain delivery of rivastigmine for the treatment of Alzheimer's disease. Biomed Pharmacother 2021;141:111829. [PMID: 34147904 DOI: 10.1016/j.biopha.2021.111829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Salatin S, Alami-Milani M, Daneshgar R, Jelvehgari M. Box-Behnken experimental design for preparation and optimization of the intranasal gels of selegiline hydrochloride. Drug Dev Ind Pharm 2018;44:1613-21. [PMID: 29932793 DOI: 10.1080/03639045.2018.1483387] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
19 Aderibigbe BA. In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases. Pharmaceutics 2018;10:E40. [PMID: 29601486 DOI: 10.3390/pharmaceutics10020040] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
20 Ahmad N, Ahmad R, Ahmad FJ, Ahmad W, Alam MA, Amir M, Ali A. Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia. Saudi J Biol Sci 2020;27:500-17. [PMID: 31889876 DOI: 10.1016/j.sjbs.2019.11.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
21 Goel H, Kalra V, Verma SK, Dubey SK, Tiwary AK. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. J Control Release 2021;341:782-811. [PMID: 34906605 DOI: 10.1016/j.jconrel.2021.12.009] [Reference Citation Analysis]
22 Alami-milani M, Zakeri-milani P, Valizadeh H, Sattari S, Salatin S, Jelvehgari M. Evaluation of anti-inflammatory impact of dexamethasone-loaded PCL-PEG-PCL micelles on endotoxin-induced uveitis in rabbits. Pharmaceutical Development and Technology 2019;24:680-8. [DOI: 10.1080/10837450.2019.1578370] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]